Correlation between coinfection with parasites, cytomegalovirus, and Clostridium difficile and disease severity in patients with ulcerative colitis

Indian Journal of Gastroenterology

Volumn 32, Issue 2, 2013, Pages 115-118

  Iyer, Venkatakrishnan H ^a,b   Augustine, Joby ^a   Pulimood, Anna B ^a   Ajjampur, Sitara Swarna Rao ^a   Ramakrishna, Balakrishnan S ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b Sterling Hospital   (India)

Author keywords

Exacerbation; Inflammatory bowel disease; Superinfection

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; IVERMECTIN; METRONIDAZOLE; TINIDAZOLE;

ADULT; ARTICLE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COLONOSCOPY; CONSERVATIVE TREATMENT; CROSS-SECTIONAL STUDY; CYST (RESTING STAGE); CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE SEVERITY; FECES ANALYSIS; FEMALE; GIARDIASIS; HISTOPATHOLOGY; HUMAN; HYMENOLEPIS NANA; INTESTINE INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NONHUMAN; PARASITE IDENTIFICATION; PARASITOSIS; PROSPECTIVE STUDY; STRONGYLE INFECTION; STRONGYLOIDES STERCORALIS; ULCERATIVE COLITIS;

EID: 84876098673     PISSN: 02548860     EISSN: 09750711     Source Type: Journal    
DOI: 10.1007/s12664-012-0302-1     Document Type: Article

References (12)

1. Sonnenberg A. Seasonal variation of enteric infections and inflammatory bowel disease. Inflamm Bowel Dis. 2008; 14: 955-9.
2. Kochhar R, Ayyagari A, Goenka MK, Dhali GK, Aggarwal R, Mehta SK. Role of infectious agents in exacerbations of ulcerative colitis in India. A study of Clostridium difficile. J Clin Gastroenterol. 1993; 16: 26{box drawings light horizontal}30.
3. Vaishnavi C, Kochhar R, Bhasin D, Thennarasu K, Singh K. Simultaneous assays for Clostridium difficile and faecal lactoferrin in ulcerative colitis. Trop Gastroenterol. 2003; 24: 13-6.
4. Balamurugan R, Balaji V, Ramakrishna BS. Estimation of faecal carriage of Clostridium difficile in patients with ulcerative colitis using real time polymerase chain reaction. Indian J Med Res. 2008; 127: 472-7.
5. Banerjee D, Deb R, Dar L, et al. High frequency of parasitic and viral stool pathogens in patients with active ulcerative colitis: report from a tropical country. Scand J Gastroenterol. 2009; 44: 325-31.
6. Ooi CJ, Fock KM, Makharia GK, et al. The Asia-Pacific consensus on ulcerative colitis. J Gastroenterol Hepatol. 2010; 25: 453-68.
7. Dinesen LC, Walsh AJ, Protic MN, et al. The pattern and outcome of acute severe colitis. J Crohns Colitis. 2010; 4: 431-7.
8. Bossuyt P, Verhaegen J, van Assche G, Rutgeerts P, Vermeire S. Increasing incidence of Clostridium difficile-associated diarrhea in inflammatory bowel disease. J Crohns Colitis. 2009; 3: 4-7.
9. Roblin X, Pillet S, Oussalah A, et al. Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis. Am J Gastroenterol. 2011; 106: 2001-8.
10. Mylonaki M, Langmead L, Pantes A, Johnson F, Rampton DS. Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool. Eur J Gastroenterol Hepatol. 2004; 16: 775-8.
11. Jess T, Simonsen J, Nielsen NM, et al. Enteric Salmonella or Campylobacter infections and the risk of inflammatory bowel disease. Gut. 2011; 60: 318-24.
12. Weinstock JV, Elliott DE. Helminths and the IBD hygiene hypothesis. Inflamm Bowel Dis. 2009; 15: 128-33.